Nature of fatigue moderates depressive symptoms and anxiety in sarcoidosis

British Journal of Health Psychology

Volumn 18, Issue 2, 2013, Pages 439-452

  De Kleijn, Willemien P E ^a,b   Drent, Marjolein ^b,d   De Vries, Jolanda ^a,b,c  

^a TILBURG UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; COMPLICATION; DEPRESSION; FATIGUE; FEMALE; FOLLOW UP; HUMAN; LUNG SARCOIDOSIS; MALE; MIDDLE AGED; PERSONALITY TEST; PROSPECTIVE STUDY; PSYCHOLOGY; QUESTIONNAIRE; SARCOIDOSIS; SEVERITY OF ILLNESS INDEX; ARTICLE; PSYCHOLOGICAL ASPECT;

ADULT; ANXIETY; DEPRESSION; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PROSPECTIVE STUDIES; QUESTIONNAIRES; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX;

EID: 84874990717     PISSN: 1359107X     EISSN: 20448287     Source Type: Journal    
DOI: 10.1111/j.2044-8287.2012.02094.x     Document Type: Article

References (53)

1. Agostini, C., Adami, F., &, Semenzato, G., (2000). New pathogenetic insights into the sarcoid granuloma. Current Opinion Rheumatology, 12, 71-76.
2. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders (Revised 4th ed.) Washington, DC: Author.
3. Baron, R. M., &, Kenny, D. A., (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51 (6), 1173-1182. doi: 10.1037/0022-3514.51.6.1173
4. Baydur, A., Alavy, B., Nawathe, A., Liu, S., Louie, S., &, Sharma, O. P., (2011). Fatigue and plasma cytokine concentrations at rest and during exercise in patients with sarcoidosis. Clinical Respiratory Journal, 5, 156-164. doi: 10.1111/j.1752-699X.2010.00214.x
5. Beekman, A. T. F., Deeg, D. J. H., Van Limbeek, J., Braam, A. W., De Vries, M. Z., &, Van Tilburg, W., (1997). Criterion validity of the Center for Epidemiologic Studies Depression Scale (CES-D): Results from a community-based sample of older subjects in the Netherlands. Psychological Medicine, 27, 231-235.
6. Bijl, R. V., Ravelli, A., &, van Zessen, G., (1998). Prevalence of psychiatric disorder in the general population: Results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Social Psychiatry and Psychiatric Epidemiology, 33, 587-595.
7. Bolling, M. Y., Kohlenberg, R. J., &, Parker, C. R., (1999). Behavior analysis and depression. In, D. M. Reno, (Ed.), Clinical behavior analysis (pp. 127-153). Nevada: Context Press.
8. Bouma, J., Ranchor, A. V., Sanderman, R., &, Van Sonderen, E., (1995). Het meten van symptomen van depressie met de ces-d-d: een handleiding. [measuring symptoms of depression with the ces-d-d: a manual]. Groningen, The Netherlands: Noordelijk Centrum voor Gezondheidsvraagstukken.
9. Brown, L. F., &, Kroenke, K., (2009). Cancer-related fatigue and its associations with depression and anxiety: A systematic review. Psychosomatics, 50, 440-447.
10. Chang, B., Steimel, J., Moller, D. R., Baughman, R. P., Judson, M. A., Yeager, H. Jr,., Rand, C. S., (2001). Depression in sarcoidosis. American Journal of Respiratory and Critical Care Medicine, 163, 329-334.
11. Costabel, U., &, Hunninghake, G. W., (1999). ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. European Respiratory Journal, 14, 735-737.
12. Cox, C. E., Donohue, J. F., Brown, C. D., Kataria, Y. P., &, Judson, M. A., (2004). Health-related quality of life of persons with sarcoidosis. Chest, 125, 997-1004. doi: 10.1378/chest.125.3.997
13. Dantzer, R., &, Kelley, K. W., (2007). Twenty years of research on cytokine-induced sickness behavior. Brain, Behavior, and Immunity, 21, 153-160. doi: 10.1016/j.bbi.2006.09.006
14. Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., &, Kelley, K. W., (2008). From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews. Neuroscience, 9, 46-56. doi: 10.1038/nrn2297
15. De Kleijn, W. P. E., De Vries, J., Lower, E. E., Elfferich, M. D. P., Baughman, R. P., &, Drent, M., (2009). Fatigue in sarcoidosis: A systematic review. Current Opinion Pulmonary Medicine, 15, 499-506. doi: 10.1097/MCP.0b013e32832d0403
16. De Kleijn, W. P. E., Drent, M., &, De Vries, J., (2011). Symptoms predict fatigue in sarcoidosis: A prospective follow-up study. Tilburg, The Netherlands: Tilburg University.
17. De Kleijn, W. P. E., Drent, M., Vermunt, J. K., Shigemitsu, H., &, De Vries, J., (2011). Types of fatigue in sarcoidosis patients. Journal of Psychosomatic Research, 71, 416-422. doi: 10.1016/j.jpsychores.2011.09.006
18. De Vries, J., &, Drent, M., (2004). Relationship between perceived stress and sarcoidosis in a Dutch patient population. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 21, 57-63.
19. De Vries, J., Rothkrantz-Kos, S., van Dieijen-Visser, M. P., &, Drent, M., (2004). The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 21, 127-136.
20. Drent, M., Lower, E. E., &, De Vries, J., (2012). Sarcoidosis associated fatigue. European Respiratory Journal, 40, 255-263. doi: 10.1183/09031936.00002512
21. Drent, M., Wirnsberger, R. M., Breteler, M. H., Kock, L. M., de Vries, J., &, Wouters, E. F., (1998). Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 15, 59-66.
22. Elfferich, M. D., De Vries, J., &, Drent, M., (2011). Type D or 'distressed' personality in sarcoidosis and idiopathic pulmonary fibrosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 28, 65-71.
23. Elfferich, M. D., Nelemans, P. J., Ponds, R. W., De Vries, J., Wijnen, P. A., &, Drent, M., (2010). Everyday cognitive failure in sarcoidosis: The prevalence and the effect of anti-TNF-α treatment. Respiration, 80, 212-219.
24. Erckens, R. J., Mostard, R. L., Wijnen, P. A., Schouten, J. S., &, Drent, M., (2012). Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis. Graefe's Archive for Clinical and Experimental Ophthalmology, 250, 713-720. doi: 10.1007/s00417-011-1844-0
25. Fouchier, S. M., Moller, G. M., Van Santen-Hoeufft, M., Faber, C. G., Smeenk, F. W., &, Drent, M., (2004). [Successful treatment with infliximab of a patient with refractory sarcoidosis]. Netherlands Journal of Medicine, 148, 2446-2450.
26. Goracci, A., Fagiolini, A., Martinucci, M., Calossi, S., Rossi, S., Santomauro, T.,., Castrogiovanni, P., (2008). Quality of life, anxiety and depression in sarcoidosis. General Hospital Psychiatry, 30, 441-445. doi: 10.1016/j.genhosppsych.2008.04.010
27. Hoitsma, E., Faber, C. G., van Santen-Hoeufft, M., De Vries, J., Reulen, J. P., &, Drent, M., (2006). Improvement of small fiber neuropathy in a sarcoidosis patient after treatment with infliximab. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 23, 73-77.
28. Iannuzzi, M. C., Rybicki, B. A., &, Teirstein, A. S., (2007). Sarcoidosis. The New England Journal of Medicine, 357, 2153-2165. doi: 10.1056/NEJMra071714
29. Katon, W., Lin, E., &, Kroenke, K., (2007). The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. General Hospital Psychiatry, 29, 147-155. doi: 10.1016/j.genhosppsych.2006.11.005
30. Kim, Y. K., Na, K. S., Shin, K. H., Jung, H. J., Choi, S. H., &, Kim, J. B., (2007). Cytokine imbalance in the pathophysiology of major depressive disorder. Progress in neuro-psychopharmacology & biological psychiatry, 31, 1044-1053. doi: 10.1016/j.pnpbp.2007.03.004
31. King, C. S., &, Kelly, W., (2009). Treatment of sarcoidosis. Disease a Month, 55, 704-718. doi: 10.1016/j.disamonth.2009.06.002
32. Konsman, J. P., Parnet, P., &, Dantzer, R., (2002). Cytokine-induced sickness behaviour: Mechanisms and implications. Trends in Neuroscience, 25, 154-159. doi: 10.1016/S0166-2236(00)02088-9
33. Korenromp, I. H. E., Grutters, J. C., Van den Bosch, J. M. M., Zanen, P., Kavelaars, A., &, Heijnen, C. J., (2011). Reduced Th2 cytokine production by sarcoidosis patients in clinical remission with chronic fatigue. Brain, Behavior, and Immunity, 25, 1498-1502. doi:org/ 10.1016/j.bbi.2011.06.004
34. Korenromp, I. H. E., Heijnen, C. J., Vogels, O. J., Van den Bosch, J. M. M., &, Grutters, J. C., (2011). Characterization of chronic fatigue in sarcoidosis in clinical remission. Chest, 140, 441-447. doi: 10.1378/chest.10-2629
35. Kroenke, K., &, Swindle, R., (2000). Cognitive-behavioral therapy for somatization and symptom syndromes: A critical review of controlled clinical trials. Psychotherapy and Psychosomatics, 69, 205-215.
36. Lower, E. E., Harman, S., &, Baughman, R. P., (2008). Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue. Chest, 133, 1189-1195. doi: 10.1378/chest.07- 2952
37. Marcellis, R. G. J., Lenssen, A. F., Elfferich, M. D. P., De Vries, J. S. K., Foerster, K., &, Drent, M., (2011). Exercise capacity, muscle strenght and fatigue in sarcoidosis. European Respiratory Journal, 38, 628-634.
38. Michielsen, H. J., De Vries, J., &, Van Heck, G. L., (2003). Psychometric qualities of a brief self-rated fatigue measure: The Fatigue Assessment Scale. Journal of Psychosomatic Research, 54, 345-352. doi: 10.1016/S0022-3999(02)00392-6
39. Michielsen, H. J., Drent, M., Peros-Golubicic, T., &, De Vries, J., (2006). Fatigue is associated with quality of life in sarcoidosis patients. Chest, 130, 989-994. doi: 10.1378/chest.130.4.989
40. Morgenthau, A. S., &, Iannuzzi, M. C., (2011). Recent advances in sarcoidosis. Chest, 139, 174-182. doi: 10.1378/chest.10-0188
41. O'Malley, P. G., Jackson, J. L., Santoro, J., Tomkins, G., Balden, E., &, Kroenke, K., (1999). Antidepressant therapy for unexplained symptoms and symptom syndromes. The Journal of Family Practice, 48, 980-990.
42. Sharma, O. P., (1999). Fatigue and sarcoidosis. European Respiratory Journal, 13, 713-714.
43. Spruit, M. A., Thomeer, M. J., Gosselink, R., Troosters, T., Kasran, A., Debrock, A. J.,., Decramer, M., (2005). Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax, 60, 32-38. doi: 10.1136/thx.2004.022244
44. SPSS Inc. (2008). SPSS for Windows, release 17.0 (Version 17.0.0). Chicago, IL: SPSS Inc.
45. Tchekmedyian, N. S., Kallich, J., McDermott, A., Fayers, P., &, Erder, M. H., (2003). The relationship between psychologic distress and cancer-related fatigue. Cancer, 98, 198-203. doi: 10.1002/cncr.11463
46. Van der Ploeg, H. M., Defares, P. B., &, Spielberger, C. D., (1980). ZBV: A Dutch-language adaptation of the Spielberger State-trait anxiety Inventory. Lisse, The Netherlands: Swets & Zeitlinger.
47. Van Esch, L., Roukema, J. A., Ernst, M. F., Nieuwenhuijzen, G. A. P., &, De Vries, J., (2012). Combined anxiety and depressive symptoms before diagnosis of breast cancer. Journal of Affective Disorders, 136, 895-901. doi: 10.1016/j.jad.2011.09.012
48. Vollmer-Conna, U., Fazou, C., Cameron, B., Li, H., Brennan, C., Luck, L.,., Lloyd, A., (2004). Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychological Medicine, 34, 1289-1297. doi: 10.1017/S0033291704001953
49. Wagner, M. T., Marion, S. D., &, Judson, M. A., (2005). The effects of fatigue and treatment with methylphenidate on sustained attention in sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 22, 235.
50. White, P., Goldsmith, K., Johnson, A., Potts, L., Walwyn, R., DeCesare, J., &, Sharpe, M., (2011). Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): A randomised trial. Lancet, 377, 823-836.
51. Wirnsberger, R. M., de Vries, J., Breteler, M. H., van Heck, G. L., Wouters, E. F., &, Drent, M., (1998). Evaluation of quality of life in sarcoidosis patients. Respiratory Medicine, 92, 750-756.
52. Wirnsberger, R. M., De Vries, J., Wouters, E. F., &, Drent, M., (1998). Clinical presentation of sarcoidosis in The Netherlands an epidemiological study. The Netherlands Journal of Medicine, 53, 53-60.
53. Yeager, H., Rossman, M. D., Baughman, R. P., Teirstein, A. S., Judson, M. A., Rabin, D. L.,., ACCESS Research Group,. (2005). Pulmonary and psychosocial findings at enrollment in the ACCESS study. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 22, 147-153.